XML 21 R10.htm IDEA: XBRL DOCUMENT
v3.23.3

Intangible Assets, Net | 9 Months Ended
--- | ---
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets, Net | Intangible Assets, Net At September 30, 2023, the Company’s intangible assets, net, consisted of the following (in thousands):
| Useful Life (Years) |  | Gross September 30, 2023 |  | Accumulated Amortization |  | Net September 30, 2023
Indefinite lived assets: |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | (102,603) |  |  | 48,076 |
Management contracts | 15 |  | 22,832 |  |  | (16,322) |  |  | 6,510 |
Member relationships | 10-14 |  | 23,444 |  |  | (6,764) |  |  | 16,680 |
Patient management platform | 5 |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | (295) |  |  | 716 |
Developed technology | 6 |  | 107 |  |  | (30) |  |  | 77 |
|  |  | $ | 202,283 |  |  | $ | (128,074) |  |  | $ | 74,209 |
At December 31, 2022, the Company’s intangible assets, net, consisted of the following (in thousands):
| Useful Life (Years) |  | Gross December 31, 2022 |  | Accumulated Amortization |  | Net December 31, 2022
Indefinite lived assets: |  |  |  |  |  |  |
Trademarks | N/A |  | $ | 2,150 |  |  | $ | — |  |  | $ | 2,150 |
Amortized intangible assets: |  |  |  |  |  |  |
Network relationships | 11-21 |  | 150,679 |  |  | (95,451) |  |  | 55,228 |
Management contracts | 15 |  | 22,832 |  |  | (15,208) |  |  | 7,624 |
Member relationships | 12 |  | 16,633 |  |  | (5,619) |  |  | 11,014 |
Patient management platform | 5 |  | 2,060 |  |  | (2,060) |  |  | — |
Tradename/trademarks | 20 |  | 1,011 |  |  | (257) |  |  | 754 |
Developed technology | 6 |  | 107 |  |  | (16) |  |  | 91 |
|  |  | $ | 195,472 |  |  | $ | (118,611) |  |  | $ | 76,861 |
For the three months ended September 30, 2023 and 2022, the Company recognized amortization expense of $3.2 million and $3.4 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations. For the nine months ended September 30, 2023 and 2022, the Company recognized amortization expense of $9.5 million and $10.6 million, respectively, in depreciation and amortization on the accompanying consolidated statements of operations. The Company determined that there was no impairment of its finite-lived intangible or long-lived assets during the nine months ended September 30, 2023 and 2022. Future amortization expense is estimated to be as follows for the following years ending December 31 (in thousands):
| Amount
2023 (excluding the nine months ended September 30, 2023) | $ | 3,173 |
2024 | 12,715 |
2025 | 11,573 |
2026 | 10,156 |
2027 | 8,729 |
Thereafter | 25,713 |
Total | $ | 72,059 |

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350-30/tableOfContent + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration